Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Wei Z, Yang X, Ye X, et al. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol. 2020;30(5):2692–2702.
   PubMed Web of Science ®Google Scholar
• Xu S, Qi J, Li B, et al. Survival prediction for non-small cell lung cancer patients treated with CT-guided microwave ablation: development of a prognostic nomogram. Int J Hyperthermia. 2021;38(1):640–649.
   PubMed Web of Science ®Google Scholar
• Wu YL, Planchard D, Lu S, et al. Pan-Asian adapted clinical practice guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS. Ann Oncol. 2019;30(2):171–210.
   PubMed Web of Science ®Google Scholar
• Rangamuwa K, Leong T, Weeden C, et al. Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res. 2021;10(6):2842–2857.
   PubMed Web of Science ®Google Scholar
• Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and Meta-analysis. Eur Radiol. 2021;31(7):5421–5433.
   PubMed Web of Science ®Google Scholar
• Li M, Xu X, Qin Y, et al. Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients. J Cancer. 2021;12(10):3057–3066.
   PubMed Web of Science ®Google Scholar
• Zeng C, Lu J, Tian Y, et al. Thermal ablation versus wedge resection for stage I non-small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database. Front Oncol. 2020;10:571684.
   PubMed Web of Science ®Google Scholar
• Li M, Qin Y, Mei A, et al. Effectiveness of radiofrequency ablation therapy for patients with unresected stage IA non-small cell lung cancer. J Can Res Ther. 2020;16(5):1007–1013.
   PubMed Web of Science ®Google Scholar
• Kwan SW, Mortell KE, Talenfeld AD, et al. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer. J Vasc Interv Radiol. 2014;25(1):1–9.e1.
   PubMed Web of Science ®Google Scholar
• Yao W, Lu M, Fan W, et al. Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis. Int J Hyperthermia. 2018;34(8):1329–1336.
   PubMed Web of Science ®Google Scholar
• Liu B, Liu L, Hu M, et al. Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer. Thorac Cancer. 2015;6(3):327–333.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology. 2001;220(2):420–427.
   PubMed Web of Science ®Google Scholar
• Li C, Wang J, Shao JB, et al. Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone. Thorac Cancer. 2019;10(7):1628–1635.
   PubMed Web of Science ®Google Scholar
• Yu S, Wu ZZ, Si HT, et al. Short-term effect analysis of radiofrequency ablation combined chemotherapy on Middle and late period non-small cell lung cancer. Oncol Lett. 2016;12(6):4399–4402.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ye X, Yang X, et al. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol. 2015;32(2):464.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ye X, Yang X, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2015;38(1):135–142.
   PubMed Web of Science ®Google Scholar
• Lee H, Jin GY, Han YM, et al. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy. Cardiovasc Intervent Radiol. 2012;35(2):343–350.
   PubMed Web of Science ®Google Scholar
• Shah S, Gosain R, Groman A, et al. Incidence and survival outcomes in patients with lung neuroendocrine neoplasms in the United States. Cancers (Basel). 2021;13(8):1753.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-Event end points in image-guided tumor ablation: Results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540.
   PubMed Web of Science ®Google Scholar
• Zhao ZR, Situ DR, Lau R, et al. Comparison of segmentectomy and lobectomy in stage IA adenocarcinomas. J Thorac Oncol. 2017;12(5):890–896.
   PubMed Web of Science ®Google Scholar
• Yi L, Fan J, Qian R, et al. Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: a meta-analysis. Int J Cancer. 2019;145(1):284–294.
   PubMed Web of Science ®Google Scholar
• Rossi A, Chiodini P, Sun JM, et al. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol. 2014;15(11):1254–1262.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• John JB, Anderson M, Dutton T, et al. Percutaneous microwave ablation of renal masses in a UK cohort. BJU Int. 2021;127(4):486–494.
   PubMed Web of Science ®Google Scholar
• Ni Y, Xu H, Ye X. Image-guided percutaneous microwave ablation of early-stage non-small cell lung cancer. Asia‐Pac J Clin Oncol. 2020;16(6):320–325.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu J, Yu J, et al. Review of clinical tumor ablation advance in Asia. Int J Hyperthermia. 2021;38(1):1639–1649.
   PubMed Web of Science ®Google Scholar
• Cammà C, Di Marco V, Orlando A, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol. 2005;42(4):535–540.
   PubMed Web of Science ®Google Scholar
• Kwan SW, Mortell KE, Hippe DS, et al. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. J Vasc Interv Radiol. 2014;25(10):1558–1564. quiz 1565.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Fernando HC, Hillman S, et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American college of surgeons oncology group Z4033 (alliance) trial. Cancer. 2015;121(19):3491–3498.
   PubMed Web of Science ®Google Scholar
• Schoellnast H, Deodhar A, Hsu M, et al. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol. 2012;53(8):893–899.
   PubMed Web of Science ®Google Scholar
• Chavez M, Silvestrini MT, Ingham ES, et al. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 2018;8(13):3611–3628.
   PubMed Web of Science ®Google Scholar
• Kim SW, Kim IK, Lee SH. Role of hyperoxic treatment in cancer. Exp Biol Med (Maywood). 2020;245(10):851–860.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao M, Wang J, et al. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers. AJR Am J Roentgenol. 2013;201(6):1362–1367.
   PubMed Web of Science ®Google Scholar
• Sun YH, Song PY, Guo Y, et al. Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC. Genet Mol Res. 2015;14(3):10015–10025.
   PubMed Web of Science ®Google Scholar
• Leppelmann KS, Mooradian MJ, Ganguli S, et al. Thermal ablation, embolization, and selective internal radiation therapy combined with checkpoint inhibitor cancer immunotherapy: Safety analysis. J Vasc Interv Radiol. 2021;32(2):187–195.
   PubMed Web of Science ®Google Scholar